FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1237262009: Receptor tyrosine-protein kinase erbB-2 inhibitor therapy (procedure)


Status: current, Defined. Date: 31-Aug 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5091385017 Human epidermal growth factor receptor 2 inhibitor therapy en Synonym Active Case insensitive SNOMED CT core
5091386016 Human epidermal growth factor receptor 2 targeted therapy en Synonym Active Case insensitive SNOMED CT core
5091387013 Receptor tyrosine-protein kinase erbB-2 inhibitor therapy (procedure) en Fully specified name Active Initial character case insensitive SNOMED CT core
5091388015 HER2 (Human epidermal growth factor receptor 2) inhibitor therapy en Synonym Active Case sensitive SNOMED CT core
5091398014 Receptor tyrosine-protein kinase erbB-2 inhibitor therapy en Synonym Active Initial character case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Receptor tyrosine-protein kinase erbB-2 inhibitor therapy Is a Drug therapy true Inferred relationship Some
Receptor tyrosine-protein kinase erbB-2 inhibitor therapy Has intent Therapeutic true Inferred relationship Some 2
Receptor tyrosine-protein kinase erbB-2 inhibitor therapy Method Administration - action true Inferred relationship Some 1
Receptor tyrosine-protein kinase erbB-2 inhibitor therapy Direct substance Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Procedure foundation reference set

Australian dialect reference set

Description inactivation indicator reference set

Back to Start